8th Circ. Revives KV Antifungal Cream Trade Secrets Row

Law360, New York (August 3, 2011, 4:13 PM EDT) -- The Eighth Circuit on Wednesday reopened a trade secrets battle between St. Louis-based drugmaker KV Pharmaceutical Co. and Spanish pharmaceutical company J Uriach & CIA SA stemming from a failed contract to jointly develop an antifungal cream.

KV filed suit in October 2009 in Missouri federal court, claiming Barcelona-based Uriach breached their contract and stole KV’s confidential information to launch its own version of the antifungal cream. The contract and trade secrets claims each sought at least $1 million in damages.

A judge dismissed the suit...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.